NewslettersProstate Cell NewsUncategorizedP2Y1 Agonist HIC in Combination with Androgen Receptor Inhibitor Abiraterone Acetate Impairs Cell Growth of Prostate CancerBy Justin.choi - February 11, 2022010Researchers evaluated the combinatorial effect of HIC with abiraterone acetate targeted on androgen receptor on the inhibition of prostate cancer cells.[Apoptosis] 7992332 {7992332:AAAAAAAA} apa 50 1 171744 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article